Richmond Laboratories placed negotiable debt securities at ten years for over $7.6 mn

The Argentine-owned pharmaceutical company Laboratorios Richmond, successfully tendered its third series of negotiable debt securities for an amount of $7.6 million equivalent to more than 600 million pesos, well above the initial expectation of $5 million. The 10-year financing term achieved by the laboratory is unprecedented in the Argentine market.

Source: Ámbito